Skip to main content

Tissue fragment injection system

Project Overview

Certain models of cancer require surgical implantation of tissue fragments. Percutaneous injection is the preferred method for implantation over open surgery because it is less invasive. Percutaneous methods have limitations including: difficulty suturing the site of incision, tumor seeding in unwanted areas, and backflow of tumor fragments during procedure. Our goal is to design an improved tissue fragment injection system that effectively eliminates these complications while lowering the technical skill needed to perform the procedure.

Team Picture

Left to Right:
James Dorrance,
Ashley Quinn,
Andrew Osterbauer, 
Emma Weinberger
Left to Right: James Dorrance, Ashley Quinn, Andrew Osterbauer, Emma Weinberger

Files

Contact Information

Team Members

  • Ashley Quinn - Team Leader
  • James Dorrance - Communicator
  • Emma Weinberger - BSAC
  • Andrew Osterbauer - BWIG

Advisor and Client

  • Prof. Randolph Ashton - Advisor
  • Prof. Chris Brace - Client
Back to Top